Type
. The utility of animal models for selection of a candidate vaccine for leprosy. Indian journal of leprosy. 1991;63(2):153-8.
Type
. Dr. Dharmendra. Born: 1-2-1900 died: 10-3-1991. Indian journal of leprosy. 1991;63(2):147-52.
Type
. [Enzyme-histochemical and Feulgen-cytophotometric studies on cells of the cutaneous connective tissue in inflammations and tumor growth]. Zeitschrift fur Hautkrankheiten. 1975;suppl 1:1-48.
Type
. Inhibition of apoptosis, activation of NKT cell and upregulation of CD40 and CD40L mediated by M. leprae antigen(s) combined with Murabutide and Trat peptide in leprosy patients. Molecular and cellular biochemistry. 2008;309(1-2):87-97.
Type
. Evaluation of bone and mineral metabolism in patients recently diagnosed with leprosy. The American journal of the medical sciences. 2007;334(5):322-6.
Type
. Leprosy in the early medieval Lauchheim community. American journal of physical anthropology. 2008;135(3):301-10.
Type
. [Type 1 reaction in leprosy: characteristics and association with hepatitis B and C viruses]. Revista da Sociedade Brasileira de Medicina Tropical. 2007;40(5):546-9.
Type
. [Detection of new cases of leprosy in the City of Prudentópolis, PR: the analysis from 1998 to 2005]. Revista da Sociedade Brasileira de Medicina Tropical. 2007;40(5):541-5.
Type
. Risk and protective factors for leprosy development determined by epidemiological surveillance of household contacts. Clinical and vaccine immunology : CVI [Internet]. 2008;15(1):101-5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223848/pdf/0372-07.pdf
Type
. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline. The American journal of tropical medicine and hygiene. 2007;77(5):829-33.